Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Colorcon
Harvard Business School
AstraZeneca
Moodys

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ESTRONE

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Estrone

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00010712 Effects of Black Cohosh on Menopausal Hot Flashes Completed National Center for Complementary and Integrative Health (NCCIH) Phase 2 1999-09-01 This study will assess whether treatment with black cohosh is effective in reducing the frequency and intensity of menopausal hot flashes. In addition, this study will determine whether or not black cohosh reduces the frequency of other menopausal symptoms and improves quality of life.
NCT00187655 Effect of, OAT3, on the Renal Secretion of Cefotaxime Completed University of California, San Francisco Phase 1 2004-01-01 In the proposed study, we plan to use a genotype to phenotype strategy to study the role of the organic anion transporter, OAT3, in drug response. More specifically we will examine the contribution of OAT3 to the renal clearance of anionic drugs such as cefotaxime by studying individuals with a non-functional (or poorly-functional) variant of OAT3.
NCT00217659 S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer Withdrawn National Cancer Institute (NCI) Phase 2 2005-09-01 RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using goserelin and anastrozole may fight breast cancer by blocking the use of estrogen by the tumor cells. Giving goserelin together with anastrozole may be an effective treatment for male breast cancer. PURPOSE: This phase II trial is studying how well giving goserelin together with anastrozole works in treating men with recurrent or metastatic breast cancer.
NCT00217659 S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer Withdrawn Southwest Oncology Group Phase 2 2005-09-01 RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using goserelin and anastrozole may fight breast cancer by blocking the use of estrogen by the tumor cells. Giving goserelin together with anastrozole may be an effective treatment for male breast cancer. PURPOSE: This phase II trial is studying how well giving goserelin together with anastrozole works in treating men with recurrent or metastatic breast cancer.
NCT00228956 Aromatase Inhibitor Clinical Trial Unknown status Indiana University School of Medicine Phase 4 2005-01-01 You are invited to participate in a research study looking at metabolism (breakdown) and effects of aromatase inhibitors. The purpose of this research is to try to identify which women who take an aromatase inhibitor are more likely to have certain benefits or side effects from the drug. We will do so by determining whether there are differences that normally occur in genes that you have inherited from your parents that might influence the way individuals respond to medications. If you agree to participate in this study, you will be asked to sign this informed consent form.
NCT00228956 Aromatase Inhibitor Clinical Trial Unknown status National Institute of Environmental Health Sciences (NIEHS) Phase 4 2005-01-01 You are invited to participate in a research study looking at metabolism (breakdown) and effects of aromatase inhibitors. The purpose of this research is to try to identify which women who take an aromatase inhibitor are more likely to have certain benefits or side effects from the drug. We will do so by determining whether there are differences that normally occur in genes that you have inherited from your parents that might influence the way individuals respond to medications. If you agree to participate in this study, you will be asked to sign this informed consent form.
NCT00228956 Aromatase Inhibitor Clinical Trial Unknown status Office of Research on Women's Health (ORWH) Phase 4 2005-01-01 You are invited to participate in a research study looking at metabolism (breakdown) and effects of aromatase inhibitors. The purpose of this research is to try to identify which women who take an aromatase inhibitor are more likely to have certain benefits or side effects from the drug. We will do so by determining whether there are differences that normally occur in genes that you have inherited from your parents that might influence the way individuals respond to medications. If you agree to participate in this study, you will be asked to sign this informed consent form.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Estrone

Condition Name

Condition Name for Estrone
Intervention Trials
Breast Cancer 13
Obesity 5
Premenstrual Syndrome 2
Hot Flashes 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Estrone
Intervention Trials
Breast Neoplasms 15
Obesity 3
Syndrome 2
Premenstrual Syndrome 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Estrone

Trials by Country

Trials by Country for Estrone
Location Trials
United States 84
Israel 2
Australia 1
United Kingdom 1
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Estrone
Location Trials
Washington 6
Illinois 5
Colorado 5
California 5
Ohio 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Estrone

Clinical Trial Phase

Clinical Trial Phase for Estrone
Clinical Trial Phase Trials
Phase 4 2
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 35
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Estrone
Clinical Trial Phase Trials
Completed 17
Active, not recruiting 7
Unknown status 6
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Estrone

Sponsor Name

Sponsor Name for Estrone
Sponsor Trials
National Cancer Institute (NCI) 13
University of Washington 4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 3
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Estrone
Sponsor Trials
Other 49
NIH 21
Industry 9
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Medtronic
Mallinckrodt
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.